I'm the same as you spaceboots - Company is still growing and penetrating new markets.
I'm giving this 12 months as well. I would want to see incremental cost reductions and increasing revenue from here over the next 3 quarters - I agree with some on here that investors with large holdings will start to question opportunity cost from being unable to invest in other booming sectors, such as BNPL, which is demonstrating more rapid growth as a sector, potentially less risk, and less barriers to profitability. This is at least the third expansion of product range - From Goat, to Cow, to Adult, to Vitamins. Would be good to understand/see more about the Bubs product narrative that binds these products together.
I think this is the last capital raise they will be able to get away with, without investors packing it in. I think there is a path to 400m, but that required sustained strategy and long-term planning which needs to start now. This is pretty much it for Bubs in my opinion, time to sink or swim.
BUB Price at posting:
91.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)